Veracyte Announces First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. JBHT
3. CRWV
4. SCHW
5. GPRK
6. TFC
7. USB
8. PNC
9. NEST:IN
10. AA

Go back to Veracyte Announces First Quarter 2019 Financial Results

Veracyte (VCYT) Tops Q1 EPS by 5c, Revenues Beat; Raises FY19 Revenue Guidance Above Consensus

April 30, 2019 5:05 PM EDT

Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $27.61 million.

We delivered excellent results in the first quarter of 2019, said Bonnie Anderson, chairman and chief executive officer of Veracyte. Product revenue and genomic volume both grew significantly in the quarter, and our biopharmaceutical service revenue exceeded our expectations. We also demonstrated financial discipline, improving our cash used in operating activities by 86%.

Anderson continued, In addition, we received a final Medicare... More